Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11767346 Modified AAV capsid proteins and uses thereof
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
March 8, 2022
Date of Patent
September 26, 2023
Patent Application Number
17689324
Patent Citations
US Patent 9157098 Transduction efficiency, capsid-modified rAAV vectors and methods of use
US Patent 7186552 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
US Patent 7220577 Modified AAV
US Patent 7927585 Production of recombinant AAV virions
US Patent 8445267 Tyrosine-modified recombinant rAAV vector compositions and methods for use
US Patent 9677088 Adeno associated virus plasmids and vectors
US Patent 9725485 AAV vectors with high transduction efficiency and uses thereof for gene therapy
US Patent 10011640 Capsid-modified rAAV vector compositions and methods therefor
US Patent 10308957 rAAV vectors and methods for transduction of photoreceptors and RPE cells
US Patent 10426844 Capsid-mutated rAAV vectors and methods of use
•••
Patent Inventor Names
Damien Marsic
Sanford L. Boye
Shannon E. Boye
Sergei Zolotukhin
Paul D. Gamlin
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11767346
Patent Primary Examiner
Rachel B Gill
CPC Code
C12N 2750/14145
C12N 2320/32
C12N 2750/14011
C12N 15/86
C12N 2750/14143
C12N 15/10
A61P 27/02
C07K 14/005
C12N 15/1037
C12N 2750/14122
•••
Find more entities like US Patent 11767346 Modified AAV capsid proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE